Riskpilot← Back to searchSign inGet full accessØSTLANDSKE HJERTESENTER AS
ASActiveOrg 818076762Carlbergveien 6A, 1526 MossMedical specialists activities · NACE 8622Est. 20167 employees
Revenue 2024
NOK 7,5M
-6% vs 2023
EBITDA margin
37.0%
+57% vs 2023
Equity ratio
61.7%
Financial strength
Net profit 2024
NOK 2M
+47% vs 2023
| Revenue | NOK 7,5M | -6% |
| EBITDA | NOK 2,8M | +57% |
| Net profit | NOK 2M | +47% |
| Total assets | NOK 3M | +10% |
| Equity | NOK 1,9M | +186% |
| Employees | 7 | — |
Legal name
ØSTLANDSKE HJERTESENTER AS
Org number
818076762
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
18. november 2016
Share capital
NOK 100 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Stefanus wilhelmus de boer
Company purpose
Drive spesialistlegepraksis, forskning relatert til hjerte-karsykdommer samt annen relevant næringsvirksomhet.
Address
Carlbergveien 6A, 1526 Moss
Phone
+4769202170
Email
hjertesenter@cardio.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 825 | 3 902 | 6 648 | 7 981 | 7 489 |
| Staff expenses | −1 226 | −1 585 | −3 494 | −4 854 | −3 783 |
| EBITDA | −78 | 608 | 1 226 | 1 763 | 2 769 |
| Depreciation & amort. | −601 | −520 | −281 | −30 | −0 |
| EBIT | −679 | 88 | 945 | 1 734 | 2 769 |
| Net financials | 0 | −0 | 0 | 17 | −191 |
| Profit before tax | −679 | 88 | 945 | 1 751 | 2 578 |
| Tax | −149 | 20 | 208 | 385 | 567 |
| Net profit | −530 | 68 | 737 | 1 366 | 2 011 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 171 | 1 126 | 1 343 | 2 751 | 3 019 |
| Equity | −1 519 | −1 451 | −713 | 652 | 1 863 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 500 | 477 | 606 | 1 048 | 1 156 |
| Total debt | 3 690 | 2 577 | 2 056 | 2 098 | 1 156 |
EBITDA margin
37.0%
This company
15.8%
Market median
+134% vs market
20202024
Equity ratio
61.7%
This company
38.2%
Market median
+62% vs market
20202024
Return on equity
107.9%
This company
18.4%
Market median
+486% vs market
20202024
Net profit margin
26.9%
This company
8.1%
Market median
+232% vs market
20202024
Asset turnover
2.48×
This company
1.12×
Market median
+121% vs market
20202024
Debt / equity
0.62×
This company
0.62×
Market median
+0% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
HE Deputy Member | Deputy Member | 2016 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Board of Directors | 2016 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
De Boer Holding As
ØSTLANDSKE HJERTESENTER AS Board members of ØSTLANDSKE HJERTESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Heidi Elisabeth Granholt Sirnes | Deputy Member | 0 companies |
| Even Harry Rønvik | Board of Directors | 0 companies |
| Per Anton Sirnes | Board of Directors | 0 companies |
| Arnfred Sandven Alvestad | Board of Directors | 0 companies |
| Randi Anita Møyland De Boer | Chairman | 0 companies |
| Stefanus Wilhelmus De Boer | Board of Directors | 0 companies |